阿托伐他汀对新疆维吾尔族急性冠脉综合征患者血清高敏C反应蛋白水平的影响 |
投稿时间:2011-05-12 修订日期:2011-05-07 点此下载全文 |
引用本文:穆叶赛·尼加提,阿木提·司马义,海热尼沙·阿不都克日木,李国庆.阿托伐他汀对新疆维吾尔族急性冠脉综合征患者血清高敏C反应蛋白水平的影响[J].医学研究杂志,2012,41(1):37-39 |
DOI:
|
摘要点击次数: 1265 |
全文下载次数: 1087 |
|
基金项目:美国中华医学基金资助项目(CMB:96-657) |
|
中文摘要:目的探讨不同剂量阿托伐他汀对新疆维吾尔族急性冠脉综合征患者血清高敏C反应蛋白水平(hs-CRP)的影响。方法将89例择期行冠脉介入治疗的维吾尔族急性冠脉综合征患者随机分为阿托伐他汀常规治疗组(对照组,20mg/d,45例)和阿托伐他汀强化治疗组(试验组,40mg/d,44例),观察治疗后4周两组患者血清高敏C反应蛋白水平(hs-CRP)。结果两组患者4周后血清hs-CRP水平均有不同程度下降,且试验组hs-CRP水平显著低于治疗前及对照组同期检测值(P<001)。结论阿托伐他汀可明显降低维吾尔族急性冠脉综合征患者血清hs-CRP水平,调脂强度与维吾尔族急性冠脉综合征患者血清hs-CRP浓度的下降趋势相关。 |
中文关键词:阿托伐他汀 急性冠脉综合征 高敏C反应蛋白 维吾尔族 |
|
Effects of Atorvastatin on hs-CRP Levels of Xinjiang Uiygur Patients with Acute Coronary Syndrome |
|
|
Abstract:ObjectiveTo investigate the effect of different doses of atorvastatin on hs-CRP levels of Xinjiang Uiygur patients suffered from acute coronary syndrome. MethodsEighty-nine acute coronary syndrome patients for Uiygur population underwent selected percutaneous coronary intervention(PCI) were enrolled. The patients were divided into two groups at random:45 cases of normal dose group(20mg/d,control group) and 44 cases of study group(40mg/d). The level of hs-CRP was measured after therapy for 4 weeks.ResultsAfter 4 weeks of therapy for the patients in the two groups,the level of hs-CRP was lower than before treatment, whereas the level of hs-CRP in study group was significantly decreased than control group(P<0.01). ConclusionAtorvastatin could decrase the level of hs-CRP in acute coronary syndrome patients for Uiygur population.The strength of adjusting the fat has correlation with the declining tendency in hs-CRP. |
keywords:Atorvastatin Acute coronary syndrome High sensitivity C reaction protein Uiygur population |
查看全文 查看/发表评论 下载PDF阅读器 |